These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 7233373)
1. [Cardiac toxicity of vincamine: a seven cases report of ventricular arrhythmias by parenteral administration of vincamine (author's transl)]. Dany F; Merle L; Goudoud JC; Liozon F; Blanc P; Bouvot JC; Nicot G; Dangoumau J Therapie; 1981; 36(1):55-64. PubMed ID: 7233373 [No Abstract] [Full Text] [Related]
2. [Severe ventricular arrhythmia following parenteral administration of vincamine. Predisposing factors in 6 cases]. Dany F; Liozon F; Goudoud JC; Castel JP; Michel JP; Marsaud P; Merle L; Dallocchio M Arch Mal Coeur Vaiss; 1980; 73(3):298-306. PubMed ID: 6779745 [TBL] [Abstract][Full Text] [Related]
3. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)]. Mikus P Arzneimittelforschung; 1978; 28(11):2165-8. PubMed ID: 582924 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of the clinical effect of vincamine versus papaverine given parenterally in the acute phase of stroke. Thiery E; Otte G; Vander Eecken H Arzneimittelforschung; 1979; 29(3):671-4. PubMed ID: 582751 [TBL] [Abstract][Full Text] [Related]
5. [Letter: Syncope due to arrhythmia. Role of vincamine apropos of 3 observations]. Laprevote-Heully MC; Lambert H; Larcan A Nouv Presse Med; 1974 Mar; 3(13):825. PubMed ID: 4836501 [No Abstract] [Full Text] [Related]
6. [Vincamine in cerebral arteriosclerosis: therapeutic effects evaluated clinically and by retinal fluoro-angiography]. Ardito R Clin Ter; 1979 Mar; 88(5):461-12. PubMed ID: 466968 [No Abstract] [Full Text] [Related]
7. [Verapamil and torsade de pointe (author's transl)]. Fanelli R; Piemontese M; Di Michele M; De Matteis D G Ital Cardiol; 1979; 9(9):1028-9. PubMed ID: 520732 [TBL] [Abstract][Full Text] [Related]
8. [Assay and bioavailability of vincamine (author's transl)]. Jaminet F; Schneck G; Polastro E; Lejeune A J Pharm Belg; 1981; 36(6):421-5. PubMed ID: 7328483 [No Abstract] [Full Text] [Related]
9. [The effect of vincamine on cerebral blood flow as a function of application rate (author's transl)]. Heiss WD; Podreka I; Samec P Arzneimittelforschung; 1977; 27(6a):1291-3. PubMed ID: 578455 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of sudden deafness. Apropos of the parenteral and peroral administration of Cerebroxine]. Vincent Y; Ermens F Acta Otorhinolaryngol Belg; 1983; 37(1):88-94. PubMed ID: 6613569 [No Abstract] [Full Text] [Related]
11. [Relative bioavailability of a vincamine retard formulation. Pharmacokinetic study in normal subjects (author's transl)]. Erking W; Lücker PW; Metz G; Specker M; Wetzelsberger K Arzneimittelforschung; 1978; 28(12):2332-6. PubMed ID: 582951 [TBL] [Abstract][Full Text] [Related]
12. [Successful resuscitation from sudden death caused by Cavinton]. Hutter K; Deli L; Csomós I Orv Hetil; 1980 Feb; 121(7):397-8. PubMed ID: 7375104 [No Abstract] [Full Text] [Related]
13. [Vincamine concentrations in plasma and cerebrospinal fluid in patients following intravenous infusion (author's transl)]. Siegers CP; Heiss WD; Kohlmeyer K Arzneimittelforschung; 1977; 27(6a):1274-7. PubMed ID: 578452 [TBL] [Abstract][Full Text] [Related]